Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis.
暂无分享,去创建一个
J Stypułkowski | M. Krawczyk | M. Wasilewicz | S. Rejowski | M. Krawczyk | M Krawczyk | Z. Lewandowski | M Grąt | K M Wronka | M Krasnodębski | Ł Masior | Z Lewandowski | I Kosińska | K Grąt | S Rejowski | M Wasilewicz | M Gałęcka | P Szachta | M. Krasnodębski | M. Grąt | J. Stypułkowski | M. Gałęcka | K. Wronka | K. Grąt | Ł. Masior | P. Szachta | I. Kosinska | I. Kosińska
[1] Aijaz Ahmed,et al. Diabetes Mellitus, and Not Obesity, Is Associated with Lower Survival Following Liver Transplantation , 2015, Digestive Diseases and Sciences.
[2] M. Krawczyk,et al. The relevance of intestinal dysbiosis in liver transplant candidates , 2015, Transplant infectious disease : an official journal of the Transplantation Society.
[3] M. Karin,et al. Inflammation and liver tumorigenesis , 2013, Frontiers of Medicine.
[4] Hongyang Wang,et al. Multiple interactive factors in hepatocarcinogenesis. , 2014, Cancer letters.
[5] B. Chassaing,et al. Microbiota‐liver axis in hepatic disease , 2014, Hepatology.
[6] K. McGlynn,et al. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. , 2015, Clinics in liver disease.
[7] Raul Rabadan,et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.
[8] Beiwen Zheng,et al. Alterations of the human gut microbiome in liver cirrhosis , 2014, Nature.
[9] K. Zieniewicz,et al. Combination of Morphologic Criteria and α-Fetoprotein in Selection of Patients With Hepatocellular Carcinoma for Liver Transplantation Minimizes the Problem of Posttransplant Tumor Recurrence , 2014, World Journal of Surgery.
[10] P. Hylemon,et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy , 2015, Hepatology.
[11] S R Tannenbaum,et al. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens , 2009, Gut.
[12] L. Tang,et al. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. , 2012, Journal of hepatology.
[13] G. Esmat,et al. Role of Helicobacter pylori in patients with HCV‐related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression , 2012, Journal of viral hepatitis.
[14] C. Sonnenday,et al. Predictors of Early Hospitalization After Deceased Donor Liver Transplantation , 2015, Digestive Diseases and Sciences.
[15] D. Pezet,et al. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. , 2014, World journal of gastroenterology.
[16] B. Sharma,et al. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy , 2011, European journal of gastroenterology & hepatology.
[17] M. Krawczyk,et al. Gut microbiota in cirrhotic liver transplant candidates. , 2014, Hepato-gastroenterology.
[18] Emmanuel Buc,et al. Colonization of the Human Gut by E. coli and Colorectal Cancer Risk , 2013, Clinical Cancer Research.
[19] Y. Chawla,et al. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. , 2014, Gastroenterology.
[20] M. Merli,et al. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. , 2014, World journal of gastroenterology.
[21] M. Krawczyk,et al. Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status , 2015, Digestive Diseases and Sciences.
[22] Long-term results of liver resection in the treatment of patients with hepatocellular carcinoma. , 2011, Polski przeglad chirurgiczny.
[23] R. Stravitz,et al. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis , 2014, Alimentary pharmacology & therapeutics.
[24] D. Brenner,et al. Role of Gut Microbiota in Liver Disease. , 2015, Journal of clinical gastroenterology.
[25] Masahira Hattori,et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.
[26] D. Pezet,et al. High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer , 2013, PloS one.
[27] N. Shinomiya,et al. Helicobacter pylori Augments Growth of Gastric Cancers via the Lipopolysaccharide-Toll-like Receptor 4 Pathway whereas Its Lipopolysaccharide Attenuates Antitumor Activities of Human Mononuclear Cells , 2008, Clinical Cancer Research.
[28] P. Gow,et al. Novel population‐based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed , 2016, Hepatology.
[29] Giuseppe Realdi,et al. Helicobacter Infection in Patients with HCV-Related Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma , 2002, Digestive Diseases and Sciences.
[30] M. Minemura,et al. Gut microbiota and liver diseases. , 2015, World journal of gastroenterology.